UnitedHealthcare, the largest health insurer in the United States, has formally joined a growing movement of healthcare organizations calling for significant structural reforms to the Independent Dispute Resolution (IDR) process established under the No Surprises Act. The insurer contends that the current administrative framework for resolving payment disagreements between providers and health plans has become ineffective, citing excessive backlogs and a process that often fails to incentivize fair-market settlements.
The No Surprises Act, which took effect on January 1, 2022, was designed to protect patients from unexpected “balance billing” when receiving care from out-of-network providers at in-network facilities. According to the Centers for Medicare & Medicaid Services (CMS), the legislation established the IDR process as a “baseball-style” arbitration mechanism intended to settle payment disputes without involving the patient. However, the operational reality has faced repeated legal challenges and administrative hurdles since its inception.
Operational Challenges and Administrative Backlogs
The core of the dispute centers on the volume and complexity of payment claims entering the federal portal. UnitedHealthcare and other industry stakeholders have pointed to the sheer number of disputes as a primary driver of inefficiency. Federal data released by the Department of Health and Human Services (HHS) indicates that the volume of IDR cases has consistently exceeded initial projections, leading to significant delays in processing times. These delays have created financial uncertainty for both healthcare providers awaiting payment and insurers managing their medical loss ratios.
For insurers, the current system is characterized by high administrative costs. The requirement to engage independent third-party arbitrators for every disputed claim—regardless of the dollar amount—is viewed by many in the industry as an unsustainable model. UnitedHealthcare’s recent feedback highlights a desire for a more streamlined approach that encourages parties to reach agreements earlier in the process, thereby reducing the burden on the federal IDR infrastructure.
Legal Precedents and Regulatory Friction
The IDR process has been the subject of multiple lawsuits since 2022, primarily brought by the Texas Medical Association and other provider groups. These legal actions have focused on how the government instructs arbitrators to weigh the “Qualifying Payment Amount” (QPA)—the median in-network rate—against other factors like provider training and patient acuity. According to rulings from the U.S. District Court for the Eastern District of Texas, federal agencies have repeatedly had to revise their guidance to ensure that arbitrators consider a broader range of evidence beyond just the QPA.
These judicial interventions have contributed to a stop-and-start environment for the IDR process. Each time the government has been forced to update its guidance, the portal has faced temporary suspensions or operational changes. For the healthcare industry, this creates a regulatory landscape where the rules of engagement for payment disputes are in constant flux. UnitedHealthcare’s stance reflects a broader sentiment among major payers that the current iteration of the act requires legislative or regulatory fine-tuning to provide long-term stability.
Impact on Providers and Payers
The disagreement over the No Surprises Act IDR process is not merely administrative; it touches on the fundamental economics of healthcare delivery. Providers argue that the QPA, as calculated by insurers, often undervalues the complexity of services provided, particularly in specialized fields like emergency medicine and anesthesiology. Conversely, insurers maintain that without a rigid adherence to market-based benchmarks, the system risks incentivizing providers to remain out-of-network to capture higher reimbursement rates.
The Government Accountability Office (GAO) has issued reports highlighting that federal agencies continue to struggle with the implementation of the IDR process, noting that the capacity of certified IDR entities remains a bottleneck. As the system matures, the debate is shifting from whether the legislation protects patients—a goal most stakeholders agree has been met—to how the financial machinery behind it can be made more efficient for the entities involved.
Future Regulatory Checkpoints
The next major update for the IDR process will likely stem from ongoing rulemaking processes managed by CMS, the Department of Labor, and the Department of the Treasury. These agencies are expected to continue issuing periodic status updates and potential adjustments to the administrative fees associated with IDR filings. Stakeholders are currently monitoring upcoming public comment periods and potential Congressional hearings that may address the long-term viability of the current dispute resolution framework.
As the industry continues to navigate these complexities, the focus remains on balancing consumer protections with a sustainable payment model. Readers interested in the latest filings or official guidance regarding the No Surprises Act should consult the federal No Surprises Act portal for the most accurate and up-to-date information. Please share your thoughts on the evolution of this policy in the comments section below.
Worth a look